New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations

Author:

Bigagli Elisabetta,Luceri Cristina,De Angioletti Maria,Chegaev Konstantin,D’Ambrosio Mario,Riganti Chiara,Gazzano Elena,Saponara Simona,Longini Mariangela,Luceri Francesca,Cinci LorenzoORCID

Funder

Ministero dell’Istruzione, dell’Università e della Ricerca (IT), FIRB 2012

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Reference48 articles.

1. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M (2009) Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138(2):245–256. https://doi.org/10.1016/j.cell.2009.04.056

2. Nakazawa M, Paller C, Kyprianou N (2017) Mechanism of therapeutic resistance in prostate cancer. Curr Oncol Rep 19(2):13. https://doi.org/10.1007/s11912-017-0568-7

3. Castro E, Romero N, Olmos D (2014) State of the art treatment in castration resistant prostate cancer. EMJ Oncol 2:100–105 https://www.emjreviews.com/oncology/article/re-state-art-treatment-castration-resistant-prostate-cancer-forward-past/re-state-of-the-art-treatment-in-castration-resistant-prostate-cancer-forward-to-the-past-again/

4. Harris WP, Mostaghel EA, Nelson PS, Montgomery B (2009) Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol 6:76–85. https://doi.org/10.1038/ncpuro1296

5. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M (2014) National Comprehensive Cancer Network. Prostate cancer, version 2.2014. J Natl Compr Cancer Netw 12(5):686–718 http://www.jnccn.org/content/12/5/686.abstract?utm_source=TrendMD&utm_medium=cpc&utm_campaign=JNCCN_TrendMD_0

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3